Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Tamarac › NPI 1144274770
Hospital

University Hospital, LTD.

University Hospital, LTD. was paid $4.49M by Medicaid between Jan 2018 and Dec 2024, across 131 billing codes. Its largest line is 99283, emergency room visit (moderate) — 30% of everything it billed.

33Billing provider infoUNIVERSITY HOSPITAL, LTD.
TAMARAC, FL 33321
33aNPI1144274770assigned 05/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.49M
24GClaims251,608
24DCodes billed131
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Florida

Rank by total paid#85 of 163
Median peer was paid$4.77M
This provider vs. median0.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201816,927$176K
201949,818$369K
202031,388$346K
202141,203$814K
202256,556$1.41M
202337,686$926K
2024incomplete18,030$451K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 30% 18,121 16,381 $1.34M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 20% 14,329 12,219 $895K
80053 Comprehensive metabolic panel 9.0% 15,384 12,170 $404K
74176 Computed tomography, abdomen and pelvis; without contrast material 6.8% 2,384 2,050 $307K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.4% 5,129 4,183 $288K
70450 Computed tomography, head or brain; without contrast material 6.4% 2,650 2,088 $287K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.1% 2,051 1,912 $141K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.8% 984 912 $81K
80048 Basic metabolic panel (calcium, ionized) 1.7% 3,158 2,584 $78K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.5% 59 53 $67K
G0378 Hospital observation service, per hour 1.3% 3,415 1,614 $60K
96361 Intravenous infusion, hydration; each additional hour 1.2% 907 803 $55K
119 more codes
71045 Radiologic examination, chest; single view <1% 8,822 $37K
71275 Computed tomographic angiography, chest, with contrast material <1% 97 $36K
87070 <1% 3,840 $34K
87040 <1% 3,454 $29K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 5,997 $24K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 697 $22K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,996 $21K
81025 <1% 3,772 $18K
87275 <1% 6,718 $16K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 2,520 $16K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 6,628 $15K
S0028 Injection, famotidine, 20 mg <1% 813 $15K
85027 <1% 20,585 $14K
80076 <1% 1,426 $14K
80047 <1% 621 $11K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,293 $10K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 8,368 $10K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,563 $9K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,086 $9K
A9270 Non-covered item or service <1% 7,116 $9K
J7030 Infusion, normal saline solution , 1000 cc <1% 7,731 $8K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 846 $8K
81001 <1% 4,702 $7K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 548 $6K
81003 <1% 2,916 $5K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,002 $5K
84702 <1% 1,169 $4K
74018 <1% 632 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,841 $4K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 257 $3K
87276 <1% 6,715 $3K
73630 <1% 235 $3K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,274 $3K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 15 $3K
84484 <1% 4,497 $3K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 298 $2K
71046 Radiologic examination, chest; 2 views <1% 576 $2K
85610 <1% 3,234 $2K
72125 Computed tomography, cervical spine; without contrast material <1% 157 $2K
96375 Therapeutic injection; each additional sequential IV push <1% 3,470 $2K
72100 <1% 252 $2K
86900 <1% 1,224 $2K
85730 <1% 3,135 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 3,233 $2K
86901 <1% 1,217 $2K
86885 <1% 457 $2K
87210 <1% 125 $2K
87076 <1% 524 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,663 $2K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 63 $1K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 15 $1K
82550 <1% 2,670 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,484 $1K
83690 <1% 3,395 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,564 $1K
73610 <1% 139 $992.11
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 30 $912.36
83605 <1% 2,431 $871.40
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 123 $864.69
82553 <1% 719 $863.39
84443 Thyroid stimulating hormone (TSH) <1% 2,585 $748.11
73030 <1% 28 $711.65
73564 <1% 112 $697.52
76801 <1% 57 $674.84
J1815 Injection, insulin, per 5 units <1% 198 $591.48
84703 <1% 1,244 $578.59
83880 <1% 1,179 $527.38
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 17 $523.49
86850 <1% 98 $486.01
J1170 Injection, hydromorphone, up to 4 mg <1% 225 $432.95
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 77 $426.20
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 66 $414.66
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 667 $398.04
73110 <1% 29 $394.32
87807 <1% 553 $382.85
J2060 Injection, lorazepam, 2 mg <1% 788 $373.99
87186 <1% 517 $366.70
87205 <1% 306 $343.09
83735 <1% 388 $338.19
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,504 $326.93
73130 <1% 36 $309.57
85379 <1% 1,010 $305.96
80143 <1% 686 $214.21
73502 <1% 18 $199.22
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program <1% 159 $189.86
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 361 $136.98
82248 <1% 467 $124.04
82077 <1% 984 $115.60
72040 <1% 34 $104.06
90714 <1% 31 $85.00
80329 <1% 1,363 $70.86
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 128 $65.72
80320 <1% 701 $50.71
80061 Lipid panel <1% 98 $14.50
83036 Hemoglobin; glycosylated (A1C) <1% 47 $3.15
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 93 $2.95
80306 0% 29 $0.00
82247 0% 79 $0.00
84155 0% 79 $0.00
J7510 Prednisolone oral, per 5 mg 0% 14 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 76 $0.00
84460 0% 79 $0.00
85007 0% 39 $0.00
90853 Group psychotherapy (other than of a multiple-family group) 0% 347 $0.00
84450 0% 79 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 79 $0.00
J3490 Unclassified drugs 0% 39 $0.00
J0500 Injection, dicyclomine hcl, up to 20 mg 0% 25 $0.00
J7060 5% dextrose/water (500 ml = 1 unit) 0% 133 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 552 $0.00
82040 0% 79 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 37 $0.00
84075 0% 79 $0.00
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 0% 16 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 110 $0.00
96376 0% 16 $0.00
86140 0% 32 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 163 $0.00
J2360 Injection, orphenadrine citrate, up to 60 mg 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLAIN, BRAD (CFO)